Search

everythinglearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Sodium valproate can worsen psoriasis-like skin conditions.

RCS-01 cell therapy is safe and improves skin gene expression.

Higher inflammation markers are linked to more severe alopecia areata.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

The new measure helps understand the personal and emotional impact of hair loss in alopecia areata patients.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

The Polish Skindex-29 is a reliable and valid questionnaire for assessing the quality of life in Polish dermatology patients.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

A patient experienced long-lasting hair loss after using acitretin for psoriasis.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Gabapentin helps with scalp itch, dutasteride works for frontal fibrosing alopecia, and more research is needed for better PCA treatments.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

PRP injections improve skin and hair quality, boost self-esteem, and are safe and satisfying for patients.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Consider DRIF and perform skin biopsies for persistent papular rashes.

The COVID-19 pandemic caused a drop in phototherapy for skin conditions, with only 40% of vitiligo and psoriasis patients returning after a hospital closure in Taiwan.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Rhupus is a complex syndrome that is hard to diagnose due to unclear clinical criteria.